Total pendapatan perusahaan BioLineRx (BLRX)

Lambang korporat lan logo BioLineRx Ltd (BLRX)

Marketing expenses for Aphexda are temporarily weighing on profitability, creating a backdrop of uncertainty. The sales trajectory for BioLineRx Ltd. (BLRX), as illustrated by the GURU.Markets data on this chart, demonstrates local dynamics, while the value of 0.00 expresses the metric level. The potential of BioLineRx Ltd. (BLRX) is based on oncology expansion through B2B partnerships, and its status as a key player is solidified by the successful launch of its cell mobilization drug.

BLRX - Pendapatan perusahaan BioLineRx ing rentang 04.07.2022 - 13.11.2026

Rincian analitis perusahaan BioLineRx (BLRX)

- nilai saham lan prakiraan konsensus rega:
Kutipan saham BioLineRx Corporation|BLRX - Bagan rega target
- rincian kapitalisasi pasar:
Nilai pasar BioLineRx Ltd.|BLRX - Nilai Total Perusahaan
- indikator nilai buku ekuitas:
Aset Bersih saben Siji Saham BioLineRx|BLRX - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku biolinerx.com|BLRX - Total Aset Perusahaan
- data liabilitas lan likuiditas perusahaan:
Rasio Utang marang Modal BioLineRx Ltd.|BLRX - Rasio utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal BioLineRx Ltd|BLRX - Gunggung utang perusahaan|Rasio utang marang aset resik BioLineRx Ltd.|BLRX - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak BioLineRx|Rasio jangkoan perantara biolinerx.com
- statistik bathi lan rasio pasar:
BLRX - Bathi resik|Bathi resik sing dikarepake BioLineRx Ltd.|BLRX - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi biolinerx.com|BLRX - Pangali PEG|Pangali EV/EBITDA BioLineRx Ltd.|BLRX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan BioLineRx|BLRX - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan biolinerx.com|BLRX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep BioLineRx Ltd.
- indikator volume dodolan lan pendapatan:
BLRX - Pendapatan lan volume dodolan|Dodolan mangsa ngarep perusahaan BioLineRx Corporation|BLRX - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep BioLineRx Ltd.
Analisis umum perusahaan:BioLineRx Corporation - BLRX
Produk seri BioLineRx Ltd.

BioLineRx Ltd. (BLRX) sales reflect the aggregate daily cash inflow from product realization. By analyzing the company's sales dynamics, an investor can filter out market noise and identify long-term fundamental trends. This metric measures operational efficiency via daily revenue, allowing for a comparison of current growth rates against historical cycles. For BioLineRx Ltd. (BLRX), such indicators confirm the commercial success of their innovative drugs in the therapy of hematological diseases.

Perusahaan pesaing

Dodolan perusahaan Incyte Pharma (INCY)|Pendapatan perusahaan HUTCHMED (China) Limited (HCM)|NUVB - Total pendapatan perusahaan|Pendapatan perusahaan Day One Biopharmaceuticals DAWN|Monopar Therapeutics Inc - Pendapatan perusahaan|INBX - Pendapatan perusahaan|Total pendapatan perusahaan I-Mab|FENC: Pendapatan lan volume dodolan|Total volume dodolan perusahaan Heron Therapeutics, Inc. HRTX|Dodolan perusahaan NVCT|Total pendapatan perusahaan Coherus BioSciences Inc. CHRS|Dodolan perusahaan CRBP (Corbus Pharma)|CRDF (cardiffoncology.com) - Pendapatan dodolan perusahaan|BeyondSpring Inc. - Dodolan perusahaan|Total dodolan perusahaan BCAB (BioAtla Inc)|Lixte Biotechnology Holdings, Inc. - Pendapatan lan volume dodolan|Pendapatan dodolan perusahaan CTXR (Citius Pharmaceuticals)|CLRB: Pendapatan lan volume dodolan|Total pendapatan perusahaan Can-Fite (CANF)|Pendapatan perusahaan Aprea Therapeutics Inc.|KZIA: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan SLXN|Pendapatan lan volume dodolan nucana.com (NCNA)|Pendapatan perusahaan Chimerix, Inc CMRX|CYCC (Cyclacel, Inc.) - Pendapatan tahunan perusahaan|GTHX: Dodolan perusahaan|Total pendapatan perusahaan kronosbio.com|KTRA: Pendapatan lan volume dodolan|ONCT (Oncternal Therapeutics Inc) - Pendapatan perusahaan|PRTG (Portage) - Pendapatan lan volume dodolan